BIOSYNTH S.R.L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BIOSYNTH S.R.L..The latest application filed is for "glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria".

Company Profile

7.13.7

BIOSYNTH S.R.L. - Rapolano Terme IT
BIOSYNTH S.R.L. - Rapolano Terme (SI) IT
BIOSYNTH S.R.L. - Rapolano Terme (Siena) IT
Biosynth S.r.l. - Siena IT
Biosynth Srl - Rapolano Terme Siena

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria Grant 11,246,919 - Porro February 15, 2	2022-02-15
Multivalent glycoconjugate vaccines Grant 11,147,872 - Porro October 19, 2	2021-10-19
Glycoconjugate Vaccines Comprising Basic Units Of A Molecular Construct Expressing Built-in Multiple Epitopes For The Formulation Of A Broad-spectrum Vaccine Against Infections Due To Enteropathogenic Bacteria App 20210138059 - PORRO; Massimo	2021-05-13
Glycoconjugate Vaccines Comprising Basic Units Of A Molecular Construct Expressing Built-in Multiple Epitopes For The Formulatio App 20200129606 - PORRO; Massimo	2020-04-30
Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria Grant 10,500,263 - Porro Dec	2019-12-10
Multivalent Glycoconjugate Vaccines App 20190224309 - PORRO; Massimo	2019-07-25
Multivalent Glycoconjugate Vaccines App 20190224310 - PORRO; Massimo	2019-07-25
Multivalent glycoconjugate vaccines Grant 10,300,135 - Porro	2019-05-28
Glycoconjugate Vaccines Comprising Basic Units Of A Molecular Construct Expressing Built-in Multiple Epitopes For The Formulation Of A Broad-spectrum Vaccine Against Infections Due To Enteropathogenic Bacteria App 20170209563 - PORRO; Massimo	2017-07-27
Multivalent Glycoconjugate Vaccines App 20170143821 - PORRO; Massimo	2017-05-25
Polysaccharide and glycoconjugate vaccines Grant 7,588,765 - Porro September 15, 2	2009-09-15
Polymyxin B analogs for LPS detoxification Grant 7,507,718 - Porro , et al. March 24, 2	2009-03-24
Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases Grant 6,951,652 - Porro October 4, 2	2005-10-04
Peptides for neutralizing the toxicity of Lipid A Grant 5,652,211 - Porro July 29, 1	1997-07-29
Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock Grant 5,589,459 - Porro December 31, 1	1996-12-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.